Actualités et vidéos - GB SCIENCES INC. GBLX

GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement PR Newswire LAS VEGAS, Nov. 18, 2019 The Sale, Which Immediately Eliminates Substantial Cash Obligations and Operating Expenses, Is Collateralized by Wellcana Plus's Interest in GB Sciences Louisiana. LAS VEGAS , Nov. 18, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) completed the sale on...

The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed PR Newswire LAS VEGAS, Nov. 6, 2019 LAS VEGAS , Nov. 6, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces a delay in the sale of GB Sciences Louisiana LLC. On September 16, 2019, GB Sciences, Inc. (the "Company"), filed a Current Report on Form 8-K disclosing that the Company had signed a term sheet with K2 Logic, LLC ("K2") pursuant to which K2 will pursue the purchase of the Company's 50% ownership...

GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors PR Newswire LAS VEGAS, Oct. 31, 2019 LAS VEGAS , Oct. 31, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce that on October 23 rd Mr. Edmond DeFrank joined its Board of Directors, filling a vacant seat. Mr. DeFrank is an attorney in the cannabis sector with deep expertise in patents and intellectual property. Mr. DeFrank brings a host of skills and...

GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine PR Newswire LAS VEGAS, Oct. 9, 2019 In the October 2019 Issue of Marijuana Business Magazine, Dr. Andrea Small-Howard Explains Why GBS is Well Positioned in New Market Segments as the Medical Cannabis Industry Evolves LAS VEGAS , Oct. 9, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is featured in the October 2019 edition of the Marijuana Business Magazine. This edition (...

GB Sciences Sells Its Louisiana Medical Marijuana Business At A $32 Million Total Valuation PR Newswire LAS VEGAS, Sept. 17, 2019 LAS VEGAS , Sept. 17, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), on Friday, September 13, 2019 , filed an 8k announcing the sale of its 50% ownership stake in GB Sciences Louisiana, LLC. The stake will be purchased by Wellcana Plus LLC, affiliated through its managers with the group which holds the other 50% of the Louisiana operations. Expected to close by...

U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers PR Newswire LAS VEGAS, Sept. 3, 2019 LAS VEGAS , Sept. 3, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends to distribute regulations...

GB Sciences Names Darin Carpenter as Executive Vice President of Cannabis Operations PR Newswire LAS VEGAS, Aug. 28, 2019 LAS VEGAS , Aug. 28, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced the appointment to GB Sciences' executive team of Darin Carpenter as the company's new Executive Vice President for Operations and General Manager, bringing his extensive and nationally-recognized experience streamlining production, improving product quality, and increasing profitability...

GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists PR Newswire LAS VEGAS, Aug. 7, 2019 Education program includes evidence-based review of FDA-registered human clinical trial data supporting the use of cannabis to treat approved medical conditions. LAS VEGAS , Aug. 7, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announced that its subsidiary GB Sciences Louisiana will hold a series of seminars in August, in partnership with...

History Made! GB Sciences Louisiana Announces Medical Cannabis Products Now for Sale for First Time in State History PR Newswire BATON ROUGE, La., Aug. 6, 2019 BATON ROUGE, La. , Aug. 6, 2019 /PRNewswire/ -- GB Sciences Louisiana (OTCQB: GBLX) today announced that its medical cannabis products, developed in partnership with LSU AgCenter's Therapeutic Cannabis Program, are available for sale to qualified patients in the state's nine licensed pharmacies. This is the first time that qualified...

GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations In the US, chronic pain represents an estimated health burden of between $560 and $650 billion dollars. PR Newswire LAS VEGAS, July 17, 2019 LAS VEGAS , July 17, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), through its subsidiary, GBS Global Biopharma, Inc. ("GBS", Ottawa, CANADA ), has filed a novel patent application to protect proprietary formulations for chronic...

GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients PR Newswire LAS VEGAS, June 11, 2019 Oral thin films provide a convenient and accurate delivery system with increased bioavailability of cannabis active ingredients for patients LAS VEGAS , June 11, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB:GBLX) today announced it has obtained an exclusive license to formulate, manufacture, and sell cannabis-infused oral thin films...

GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies GBS Global Biopharma's proprietary neuropathic pain therapies are orally-delivered, time-released nanoparticles containing myrcene and other cannabinoid-based ingredients PR Newswire OTTAWA, Ontario, May 28, 2019 OTTAWA, Ontario , May 28, 2019 /PRNewswire/ -- GBS Global Biopharma, Inc. ("GBS Global"), a Canadian-based subsidiary of GB Sciences, Inc. (OTCQB:GBLX), announced...

GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility Positioned to Increase Revenue by Approximately $5.6 Million PR Newswire LAS VEGAS, May 14, 2019 LAS VEGAS , May 14, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced it is nearing completion of $700,000 in power and water upgrades at its cultivation facility in Las Vegas, NV , which will more than triple the company's flower production capabilities. The upgrades will allow GB Sciences to expand...

GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center Increases production and ensures a continuous supply of therapeutic cannabis for Louisiana patients. PR Newswire LAS VEGAS, April 16, 2019 LAS VEGAS , April 16, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), a partner in GB Sciences Louisiana, LLC, is announcing that all cultivation operations at LSU Agricultural Center are now open. This...

Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times PR Newswire LAS VEGAS, April 2, 2019 LAS VEGAS , April 2, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announced that Dr. Dominick Monaco , GB Sciences' Director of Medical Formulations, will be a featured speaker at the Las Vegas Cannabis Conference TODAY, April 2 , at 4:40pm . He will...

GB Sciences Study Shows Nevada's Cannabis Strain Names Have No Correlation to Active Ingredients What consumers see is not what they get: Study finds almost no chemical diversity in Nevada's cannabis varieties PR Newswire LAS VEGAS, March 28, 2019 LAS VEGAS , March 28, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced results from a new study that shows only three chemical varieties of cannabis were sold in the Nevada dispensaries between January 2016 and June 2017 -- despite...

In Case You Missed It: GB Sciences Approved For Full Operations In Main LSU AgCenter Production Facility With over five times the production capacity, main facility will allow for a perpetual harvest cycle, ensuring a continuous supply of therapeutic cannabis for patients throughout Louisiana. PR Newswire LAS VEGAS, March 26, 2019 LAS VEGAS , March 26, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced that The LSU Agricultural Center (AgCenter) received confirmation from the...

Louisiana Agriculture Commissioner Approves GB Sciences To Begin Full Operations In Main LSU AgCenter Production Facility With over five times the production capacity, main facility will allow for a perpetual harvest cycle, ensuring a continuous supply of therapeutic cannabis for patients throughout Louisiana. PR Newswire LAS VEGAS, March 22, 2019 LAS VEGAS , March 22, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced that The LSU Agricultural Center (AgCenter) received...

GB Sciences Launches Global Expansion in Canada with GBS Global Biopharma, Inc. PR Newswire LAS VEGAS, March 19, 2019 Expedites innovative cannabinoid medicine program, covering 60 disease and health conditions including Parkinson's Disease, neuropathic pain and cardiac hypertrophy LAS VEGAS , March 19, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today launched a global expansion strategy with the formation of GBS Global Biopharma Inc. ("GBS Global"), a cannabinoid medicine company...

GB Sciences Supports the Position of LSU AgCenter: Allegations Made by Commissioner Are Untrue LSU AgCenter issued the following statement on Friday, March 8th. PR Newswire LAS VEGAS, March 12, 2019 LAS VEGAS , March 12, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that the Louisiana State University Agricultural Center (LSU AgCenter) through William B. Richardson , Vice President for Agriculture, today issued the following statement on allegations made by the Commissioner of...